Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1992-3-24
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0002-953X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
149
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
420-1
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:1531582-Buspirone,
pubmed-meshheading:1531582-Clinical Trials as Topic,
pubmed-meshheading:1531582-Clomipramine,
pubmed-meshheading:1531582-Humans,
pubmed-meshheading:1531582-Meta-Analysis as Topic,
pubmed-meshheading:1531582-Obsessive-Compulsive Disorder,
pubmed-meshheading:1531582-Psychiatric Status Rating Scales
|
pubmed:year |
1992
|
pubmed:articleTitle |
Serotonin and effect sizes of antiobsessive agents.
|
pubmed:publicationType |
Letter,
Comment,
Meta-Analysis
|